Catalase deficiency renders remnant kidneys more susceptible to oxidant tissue injury and renal fibrosis in mice

Kidney International

Volumn 68, Issue 3, 2005, Pages 1018-1031

  Kobayashi, Mizuho ^b   Sugiyama, Hitoshi ^a   Wang, Da Hong ^b   Toda, Naomi ^b   Maeshima, Yohei ^b   Yamasaki, Yasushi ^b   Masuoka, Noriyoshi ^b   Yamada, Masao ^b   Kira, Shohei ^b   Makino, Hirofumi ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b NONE

Author keywords

5 6 nephrectomy; Acatalasemic mice; Albuminuria; Interstitial fibrosis; Peroxidation

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALPHA SMOOTH MUSCLE ACTIN; CATALASE; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; FIBROBLAST SPECIFIC PROTEIN 1; GLUTATHIONE PEROXIDASE; LIPID; PROTEIN; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CATALASE DEFICIENCY; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GLOMERULOSCLEROSIS; HOMOZYGOSITY; INTERSTITIAL NEPHRITIS; KIDNEY FIBROSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY INTERSTITIUM; LIPID PEROXIDATION; MALE; MOUSE; MOUSE STRAIN; NEPHRECTOMY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; SPECIES COMPARISON; TISSUE INJURY; UPREGULATION; WILD TYPE;

ALBUMINURIA; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; BODY WEIGHT; CATALASE; COLLAGEN TYPE I; COLLAGEN TYPE IV; CYCLIC N-OXIDES; EPITHELIAL CELLS; FIBROSIS; GLUTATHIONE PEROXIDASE; KIDNEY DISEASES; KIDNEY GLOMERULUS; LIPID PEROXIDATION; MALE; MESODERM; MICE; MICE, INBRED C3H; MICE, MUTANT STRAINS; NEPHRECTOMY; ORGAN SIZE; OXIDATIVE STRESS; SPIN LABELS; SUPEROXIDE DISMUTASE;

EID: 32644478793     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00494.x     Document Type: Article

References (54)

1. PINZANI M, ROMBOUTS K: Liver fibrosis: from the bench to clinical targets. Dig Liver Dis 36:231-242, 2004
2. COOPER ME: The role of the renin-angiotensin-aldosterone system in diabetes and its vascular complications. Am J Hypertens 17:816-S20, 2004
3. HAUGEN E, NATH KA: The involvement of oxidative stress in the progression of renal injury. Blood Purif 17:58-65, 1999
4. SHIOMI T, TSUTSUI H, MATSUSAKA H, et al: Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 109:544-549, 2004
5. CHANCE B, SIES H, BOVERIS A: Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527-605, 1979
6. OSHINO N, OSHINO R, CHANCE B: The characteristics of the "peroxidatic" reaction of catalase in ethanol oxidation. Biochem J 131:555-563, 1973
7. TAKAHARA S: Acatalasemia. Lancet 2:1101-1106, 1952
8. OGATA M: Acatalasemia. Hum Genet 86:331-340, 1991
9. FEINSTEIN RN, SUTER H, JAROSLOW BN: Blood catalase polymorphism: Some immunological aspects. Science 159:638-640, 1968
10. SHAFFER JB, SUTTON RB, BEWLEY GC: Isolation of a cDNA clone for murine catalase and analysis of an acatalasemic mutant. J Biol Chem 262:12908-12911, 1987
11. HO YS, XIONG Y, MA W, et al: Mice lacking catalase develop normally but show differential sensitivity to oxidant tissue injury. J Biol Chem 279:32804-32812, 2004
12. EDDY AA: Molecular basis of renal fibrosis. Pediatr Nephrol 15:290-301, 2000
13. REMUZZI G, RUGGENENTI P, PERICO N: Chronic renal diseases: Renoprotective benefits of renin-angiotensin system inhibition. Ann Intern Med 136:604-615, 2002
14. EL-NAHAS AM: Plasticity of kidney cells: Role in kidney remodeling and scarring. Kidney Int 64:1553-1563, 2003
15. NG YY, HUANG TP, YANG WC, et al: Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 54:864-876, 1998
16. STRUTZ F, OKADA H, LO CW, et al: Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 130:393-405, 1995
17. KALLURI R, NEILSON EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112:1776-1784, 2003
18. FAN JM, NG YY, HILL PA, et al: Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 56:1455-1467, 1999
19. INOUE T, OKADA H, KOBAYASHI T, et al: Hepatocyte growth factor counteracts transforming growth factor-beta1, through attenuation of connective tissue growth factor induction, and prevents renal fibrogenesis in 5/6 nephrectomized mice. FASEB J 17:268-270, 2003
20. ZEISBERG M, KALLURI R: The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 82:175-181, 2004
21. LIU Y: Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. J Am Soc Nephrol 15:1-12, 2004
22. SUNAMI R, SUGIYAMA H, WANG DH, et al: Acatalasemia sensitizes renal tubular epithelial cells to apoptosis and exacerbates renal fibrosis after unilateral ureteral obstruction. Am J Physiol Renal Physiol 286:F1030-F1038, 2004
23. SUGIYAMA H, KASHIHARA N, MAKINO H, et al: Apoptosis in glomerular sclerosis. Kidney Int 49:103-111, 1996
24. HASHIMOTO N, MAESHIMA Y, SATOH M, et al: Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am J Physiol Renal Physiol 286:F516-F525, 2004
25. SUGAYA T, NISHIMATSU S, TANIMOTO K, et al: Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 270:18719-18722, 1995
26. TOYOKUNI S, TANAKA T, HATTORI Y, et al: Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: Its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 76:365-374, 1997
27. SATOH M, KASHIHARA N, YAMASAKI Y, et al: Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol 12:317-325, 2001
28. MAKINO H, SUGIYAMA H, YAMASAKI Y, et al: Glomerular cell apoptosis in human lupus nephritis. Virchows Arch 443:67-77, 2003
29. SUZUKI J, OTSUKA F, INAGAKI K, et al: Novel action of activin and bone morphogenetic protein in regulating aldosterone production by human adrenocortical cells. Endocrinology 145:639-649, 2004
30. XU J, SMOCK SL, SAFADI FF, et al: Cloning the full-length cDNA for rat connective tissue growth factor: Implications for skeletal development. J Cell Biochem 77:103-115, 2000
31. KAWADA N, MORIYAMA T, ANDO A, et al: Role of intron 1 in smooth muscle alpha-actin transcriptional regulation in activated mesangial cells in vivo. Kidney Int 55:2338-2348, 1999
32. IWANO M, PLIETH D, DANOFF TM, et al: Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 110:341-350, 2002
33. MASUOKA N, WAKIMOTO M, OHTA J, et al: Characterization of hydrogen peroxide removal activities in mouse hemolysates: Catalase activity and hydrogen peroxide removal activity by hemoglobin. Biochim Biophys Acta 1361:131-137, 1997
34. MASUOKA N, KODAMA H, ABE T, et al: Characterization of hydrogen peroxide removal reaction by hemoglobin in the presence of reduced pyridine nucleotides. Biochim Biophys Acta 1637:46-54, 2003
35. WAKIMOTO M, MASUOKA N, NAKANO T, UBUKA T: Determination of glutathione peroxidase activity and its contribution to hydrogen peroxide removal in erythrocytes. Acta Med Okayama 52:233-237, 1998
36. SUTHERLAND MW, LEARMONTH BA: The tetrazolium dyes MTS and XTT provide new quantitative assays for superoxide and superoxide dismutase. Free Radic Res 27:283-289, 1997
37. KAIMORI JY, TAKENAKA M, NAKAJIMA H, et al: Induction of glia maturation factor-beta in proximal tubular cells leads to vulnerability to oxidative injury through the p38 pathway and changes in antioxidant enzyme activities. J Biol Chem 278:33519-33527, 2003
38. KREN S, HOSTETTER TH: The course of the remnant kidney model in mice. Kidney Int 56:333-337, 1999
39. SCHNACKENBERG CG, WELCH WJ, WILCOX CS: Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: Role of nitric oxide. Hypertension 32:59-64, 1998
40. LIU Y: Hepatocyte growth factor in kidney fibrosis: Therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol 287:F7-F16, 2004
41. LI Y, YANG J, DAI C, et al: Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112:503-516, 2003
42. LI JH, ZHU HJ, HUANG XR, et al: Smad7 inhibits fibrotic effect of TGF-beta on renal tubular epithelial cells by blocking Smad2 activation. J Am Soc Nephrol 13:1464-1472, 2002
43. ZHANG X, LIU Y: Suppression of HGF receptor gene expression by oxidative stress is mediated through the interplay between Sp1 and Egr-1. Am J Physiol Renal Physiol 284:F1216-F1225, 2003
44. RHYU DY, YANG Y, HA H, et al: Role of reactive oxygen species in TGF-{beta}1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 16:667-675, 2005
45. ZHOU Z, KANG YJ: Cellular and subcellular localization of catalase in the heart of transgenic mice. J Histochem Cytochem 48:585-594, 2000
46. YOSHIOKA T, ICHIKAWA I, FOGO A: Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 2:902-912, 1991
47. MORIGI M, MACCONI D, ZOJA C, et al: Protein overload-induced NF-kappaB activation in proximal tubular cells requires H(2)O(2) through a PKC-dependent pathway. J Am Soc Nephrol 13:1179-1189, 2002
48. NAKAJIMA H, TAKENAKA M, KAIMORI JY, et al: Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin. J Am Soc Nephrol 15:276-285, 2004
49. CHRISTENSEN EI, BIRN H: Megalin and cubilin: multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3:256-266, 2002
50. OSICKA TM, KIRIAZIS Z, PRATT LM, et al: Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats. Diabetologia 44:230-236, 2001
51. MAKINO A, SKELTON MM, ZOU AP, COWLEY AW, JR.: Increased renal medullary H(2)O(2) leads to hypertension. Hypertension 42:25-30, 2003
52. CHEN YF, COWLEY AW, JR., ZOU AP: Increased H(2)O(2) counteracts the vasodilator and natriuretic effects of superoxide dismutation by tempol in renal medulla. Am J Physiol Regul Integr Comp Physiol 285:R827-R833, 2003
53. MA LJ, FOGO AB: Model of robust induction of glomerulosclerosis in mice: Importance of genetic background. Kidney Int 64:350-355, 2003
54. GOTH L, EATON JW: Hereditary catalase deficiencies and increased risk of diabetes. Lancet 356:1820-1821, 2000